Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease - Business Wire

Business Wire - Jan 07, 2026

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics

Sarepta Therapeutics - Nov 03, 2025

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Dec 18, 2025

Sarepta Therapeutics seeks clinical trial clearance for SRP-1005 - BioWorld MedTech

BioWorld MedTech - Jan 08, 2026

Have Insiders Sold Sarepta Therapeutics Shares Recently? - simplywall.st

simplywall.st - Dec 20, 2025

Sarepta (SRPT) Moves Forward with New Clinical Trial Application for Huntington's Treatment - GuruFocus

GuruFocus - Jan 07, 2026

Sarepta Therapeutics Applauds Addition of Duchenne Muscular Dystrophy to the U.S. Recommended Uniform Screening Panel (RUSP) - Sarepta Therapeutics

Sarepta Therapeutics - Dec 17, 2025

Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Business Wire - Jan 05, 2026

Assessing Sarepta Therapeutics (SRPT) Valuation After SRP-1005 Huntington’s Disease Trial Application - Yahoo Finance

Yahoo Finance - Jan 08, 2026

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label - Sarepta Therapeutics

Sarepta Therapeutics - Jul 16, 2025

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Business Wire - Dec 31, 2025

Why Is Sarepta Therapeutics (SRPT) Up 26.4% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Dec 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment